Hacina Gill

1 month ago | jacc.org | Amar Krishnaswamy |David Meier |Serge C. Harb |Hacina Gill

References1. "Valve-in-surgical-valve with SAPIEN 3 for transcatheter aortic valve replacement based on Society of Thoracic Surgeons Predicted Risk of Mortality". Circ Cardiovasc Interv . 2021;14:e010288. 2. "One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve". JAMA Cardiol . 2020;5:1245-1252. 3. "Transcatheter aortic valve replacement of failed surgically implanted bioprostheses: the STS/ACC registry". J Am Coll Cardiol . 2018;72:370-382. 4.

Apr 27, 2023 | citoday.com | David Meier |Stephanie Sellers |Hacina Gill |Althea Lai |Geoffrey W. Payne

Over the past 20 years, transcatheter aortic valve replacement (TAVR) with transcatheter heart valves (THVs) has proven to be a safe and effective alternative to surgical aortic valve replacement (SAVR) with bioprosthetic surgical heart valves (SHVs) or mechanical prostheses.1 While historically indicated for patients at high surgical risk, improvements in valve durability and design, the growing number of experienced operators, and consideration for patient preference have led to a shift in...